Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-02-09 @ 9:44 AM
Study NCT ID:
NCT04850560
Status:
UNKNOWN
Last Update Posted:
2021-06-09
First Post:
2021-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sequential Low-dose Decitabine With PD-1/CD28 CD19 CAR-T in Relapsed or Refractory B-cell Lymphoma
Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Objective Response Rate | View |
Keywords: